{
    "clinical_study": {
        "@rank": "109216", 
        "acronym": "QUOTA", 
        "arm_group": [
            {
                "arm_group_label": "Quadripolar LV electrode", 
                "arm_group_type": "Active Comparator", 
                "description": "Application of a quadripolar LV electrode"
            }, 
            {
                "arm_group_label": "Bipolar LV electrode", 
                "arm_group_type": "Active Comparator", 
                "description": "Application of a bipolar LV electrode"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary objective of this study is to evaluate whether the use of a quadripolar left\n      ventricular (LV) electrode compared to a standard bipolar LV electrode leads to lower\n      non-responder rates in patients undergoing cardiac resynchronization therapy (CRT)"
        }, 
        "brief_title": "Quartet\u2122 Bad Oeynhausen Trial", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Congestive Heart Failure", 
            "Cardiac Resynchronization Therapy"
        ], 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Indication for CRT-D implantation according to current guidelines\n\n          -  Ischemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM)\n\n          -  Sinus rhythm\n\n          -  NYHA II-IV\n\n          -  Age \u2265 18 years\n\n          -  Written informed consent to participate in the study\n\n        Exclusion Criteria:\n\n          -  Right bundle brunch block\n\n          -  Valvular cardiomyopathy\n\n          -  Patient receiving a non-transvenous LV electrode\n\n          -  Known pregnancy\n\n          -  Age < 18 years\n\n          -  Life expectancy < 1 year\n\n          -  Atrial fibrillation / atrial flutter at the time of enrolment\n\n          -  Inability to provide informed consent\n\n          -  Participation in another study with active therapeutic arm\n\n          -  Regular follow-up in the study center within the first 6 months after implantation\n             not guaranteed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850264", 
            "org_study_id": "HDZNRW_KA_002_KJG"
        }, 
        "intervention": {
            "arm_group_label": [
                "Quadripolar LV electrode", 
                "Bipolar LV electrode"
            ], 
            "intervention_name": "Application of quadripolar / bipolar LV electrodes", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "cardiac resynchronization therapy; heart failure, congestive", 
        "lastchanged_date": "May 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bad Oeynhausen", 
                    "country": "Germany", 
                    "zip": "32545"
                }, 
                "name": "Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum"
            }, 
            "investigator": [
                {
                    "last_name": "Klaus-Juergen Gutleben, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Georg Noelker, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bogdan G Muntean, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Quartet\u2122 Bad Oeynhausen Trial", 
        "overall_contact": {
            "email": "kjgutleben@hdz-nrw.de", 
            "last_name": "Klaus-Juergen Gutleben, M.D.", 
            "phone": "49 5731", 
            "phone_ext": "971327"
        }, 
        "overall_contact_backup": {
            "email": "akleemeyer@hdz-nrw.de", 
            "last_name": "Astrid Kleemeyer", 
            "phone": "49 5731", 
            "phone_ext": "971258"
        }, 
        "overall_official": {
            "affiliation": "Heart and Diabetes Center North Rhine-Westphalia, Department of Cardiology", 
            "last_name": "Klaus-Juergen Gutleben, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Increase in peak oxygen consumption", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Reduction of New York Heart Association (NYHA) functional class", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Survival", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850264"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Heart and Diabetes Center North-Rhine Westfalia", 
            "investigator_full_name": "Klaus Juergen Gutleben", 
            "investigator_title": "Senior cardiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Heart and Diabetes Center North-Rhine Westfalia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Heart and Diabetes Center North-Rhine Westfalia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}